| Product Code: ETC10573762 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Belgium continues to rely heavily on imports of DNA vaccines, with the USA, Austria, Netherlands, Hungary, and the UK being the top exporting countries. Despite a significant decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remains impressive at 39.8%. The market shows continued high concentration with a high Herfindahl-Hirschman Index (HHI), indicating a competitive landscape dominated by a few key players. Belgium`s import market for DNA vaccines appears robust and dynamic, with potential opportunities for further expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium DNA Vaccines Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium DNA Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium DNA Vaccines Market - Industry Life Cycle |
3.4 Belgium DNA Vaccines Market - Porter's Five Forces |
3.5 Belgium DNA Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Belgium DNA Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium DNA Vaccines Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Belgium DNA Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Belgium DNA Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium DNA Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Belgium DNA Vaccines Market Trends |
6 Belgium DNA Vaccines Market, By Types |
6.1 Belgium DNA Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium DNA Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Belgium DNA Vaccines Market Revenues & Volume, By Recombinant DNA, 2021 - 2031F |
6.1.4 Belgium DNA Vaccines Market Revenues & Volume, By Plasmid DNA, 2021 - 2031F |
6.1.5 Belgium DNA Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Belgium DNA Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium DNA Vaccines Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.2.3 Belgium DNA Vaccines Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.4 Belgium DNA Vaccines Market Revenues & Volume, By Veterinary Vaccines, 2021 - 2031F |
6.3 Belgium DNA Vaccines Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Belgium DNA Vaccines Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.3 Belgium DNA Vaccines Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.3.4 Belgium DNA Vaccines Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Belgium DNA Vaccines Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Belgium DNA Vaccines Market Revenues & Volume, By Plasmid Based, 2021 - 2031F |
6.4.3 Belgium DNA Vaccines Market Revenues & Volume, By Electroporation, 2021 - 2031F |
6.4.4 Belgium DNA Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 Belgium DNA Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Belgium DNA Vaccines Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 Belgium DNA Vaccines Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 Belgium DNA Vaccines Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 Belgium DNA Vaccines Market Import-Export Trade Statistics |
7.1 Belgium DNA Vaccines Market Export to Major Countries |
7.2 Belgium DNA Vaccines Market Imports from Major Countries |
8 Belgium DNA Vaccines Market Key Performance Indicators |
9 Belgium DNA Vaccines Market - Opportunity Assessment |
9.1 Belgium DNA Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Belgium DNA Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium DNA Vaccines Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Belgium DNA Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Belgium DNA Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium DNA Vaccines Market - Competitive Landscape |
10.1 Belgium DNA Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Belgium DNA Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here